Pathways of Implementation of Multi-Criteria Decision Analysis Into Orphan Drug Approval Procedure for Drug Supply Programs in Russian Federation

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Methodological Approaches and Use of Multiple Criteria Decision Analysis for Implementation of National Drug Policy in Ukraine

Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï
2019English

Optimization of Drug Supply for Patients With Malignant Neoplasms in a Region of the Russian Federation

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
2020English

Multi-Criteria Decision Analysis (MCDA): Testing a Proposed McDa Model for Orphan Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparison of the Expedited Programs & Orphan Drug Designation in the Usa & Japan

Indian Research Journal of Pharmacy and Science
2018English

Orphan Drug Development in China ‒ Turning Challenges Into Opportunities

Intractable and Rare Diseases Research
Medicine
2016English

Php34 - Time Analysis of the Drug Approval Process in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013English

Analysis of Benefit-Risk Balance in Decision-Making of the Food and Drug Administration for Premarket Approval of Therapeutic Medical Devices

Advanced Biomedical Engineering
Pattern RecognitionComputer VisionComputer Science ApplicationsBiomaterialsBiotechnologyBiomedical Engineering
2013English

Php86 - Importance of Criteria for Drug Reimbursement Decision-Making for Non-Life-Threatening Diseases

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy